The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Admission hyperglycemia in critically ill sepsis patients: Association with outcome and host response
Open accessAbstract
Objectives: To investigate whether admission hyperglycemia is associated with the presentation and/or outcome of sepsis, what the influence of hyperglycemia is on key host responses to sepsis, and whether hyperglycemia differentially affects patients with diabetes mellitus. Design and Setting: A substudy of a prospective observational cohort study was conducted in the intensive care of two tertiary hospitals between January 2011 and July 2013. Patients: Of all consecutive critically ill sepsis patients, admission glucose was used to stratify patients in euglycemia (71–140 mg/dL), mild hyperglycemia (141–199 mg/dL), and severe hyperglycemia (≥ 200 mg/dL), and patients with hypoglycemia were excluded. Fifteen plasma biomarkers providing insight in key host responses implicated in sepsis pathogenesis were measured on admission. Measurements and Main Results: Of 987 sepsis patients with admission glucose levels greater than 70 mg/dL, 519 (52.6%) had normal glucose levels, 267 (27.1%) had mild, and 201 (20.4%) severe hyperglycemia. Admission hyperglycemia was accompanied by mitigated alterations in plasma host response biomarker levels indicative of activation of the cytokine network, the vascular endothelium, and the coagulation system in patients without a history of diabetes. Severe, but not mild, admission hyperglycemia was associated with increased 30-day mortality (adjusted hazard ratio, 1.66 [95% CI, 1.24–2.23]), in both patients without diabetes (adjusted hazard ratio, 1.65 [95% CI, 1.12–2.42]) and with diabetes (adjusted hazard ratio, 1.91 [95% CI, 1.01–3.62]). Conclusion: Admission hyperglycemia is associated with adverse outcome of sepsis irrespective of the presence or absence of preexisting diabetes by a mechanism unrelated to exaggerated inflammation or coagulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inpatient hyperglycemia is associated with increased complications including surgical site infections, mortality, and increased length of hospital stay.91–93”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [91]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E. H., Angus, D. C., Cook, D., Cohen, J., Opal, S. M., Vincent, J., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,976
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,665
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Pierrakos, C. N., & Vincent, J. (2010) · Critical Care · doi:10.1186/cc8872 · Cited by 1,389
Krinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Calandra, T., & Cohen, J. D. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000168253.91200.83 · Cited by 840
Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects
Turina, M., Fry, D. E., & Polk, H. C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000170106.61978.d8 · Cited by 491
Stress-hyperglycemia, insulin and immunomodulation in sepsis
Marik, P. E., & Raghavan, M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2167-y · Cited by 423
Cited by
Sorted by citations
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
Sardu, C., D’Onofrio, N., Balestrieri, M. L., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., Paolisso, G., & Marfella, R. (2020) · Diabetes Care · doi:10.2337/dc20-0723 · Cited by 435
“abetes hospitalized for COVID-19 and is common among acute hospital admissions and critically ill patients, encompassing those with no previous history of hyperglycemia (1,2).”
BackgroundLu, Z., Tao, G., Sun, X., Zhang, Y., Jiang, M., Liu, Y., Ling, M., Zhang, J., Xiao, W., Hua, T., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.857368 · Cited by 134
Karampela, Ι., Christodoulatos, G. S., & Dalamaga, Μ. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00360-2 · Cited by 107
Hyperglycemia, Insulin, and Insulin Resistance in Sepsis
Rivas, A. M., & NUGENT, K. M. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.11.007 · Cited by 87
Bellaver, P., Schaeffer, A. F., Dullius, D. P., Viana, M. V., Leitão, C. B., & Rech, T. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-55080-3 · Cited by 73
Mortality from infectious diseases in diabetes
Zoppini, G., Fedeli, U., Schievano, E., Dauriz, M., Targher, G., Bonora, E., & Corti, M. C. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.12.007 · Cited by 70
Prognostic values of SOFA score, qSOFA score, and LODS score for patients with sepsis
Li, Y., Yan, C., Gan, Z., Xi, X., Tan, Z., Li, J., & Li, G. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-984 · Cited by 70
“Survival group 66 [53,77] 4,115 4,755 11 [6,20] 5 [3,7] 2 [2, 2] 4 [3,6]”
InfluentialExpert consensus on the glycemic management of critically ill patients
Wu, Z., Liu, J., Zhang, D., Kang, K., Zuo, X., Xu, Q., Pan, A., Fang, W., Liu, F., Shang, Y., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.06.001 · Cited by 67
“[77] A retrospective study of 1527 patients with ommunity-acquired sepsis showed that increased blood gluose ( ≥ 11.”
BackgroundStandage, S. W., Bennion, B. G., Knowles, T. O., Ledee, D. R., Portman, M. A., McGuire, J. K., Liles, W. C., & Olson, A. K. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00457.2016 · Cited by 63
Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea
Park, J. H., Ha, K. H., Kim, B., Lee, J. H., & Kim, D. J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0175 · Cited by 60
Control strategies in systemic metabolism
Ye, J. J., & Medzhitov, R. M. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0118-8 · Cited by 60
Kim, Y., Jin, Y., Jin, T., & Lee, S. (2020) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2020.102844 · Cited by 49
Wernly, B., Lichtenauer, M., Hoppe, U. C., & Jung, C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.24 · Cited by 47
“have investigated the relation of admission hyperglycemia in patients suffering from sepsis (1).”
BackgroundZohar, Y., Zilberman-Itskovich, S., Koren, S., Zaidenstein, R., Marchaim, D., & Koren, R. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02507-9 · Cited by 39
Hyperglycaemia in critically ill patients: the immune system’s sweet tooth
van Niekerk, G., Davis, T., & Engelbrecht, A. (2017) · Critical Care · doi:10.1186/s13054-017-1775-1 · Cited by 34
Olander, A., Andersson, H., Sundler, A. J., Bremer, A., Ljungström, L., & Hagiwara, M. A. (2019) · BMC Emergency Medicine · doi:10.1186/s12873-019-0255-0 · Cited by 40
Wang, W., Chen, W., Liu, Y., Li, L., Li, S., Tan, J., & Sun, X. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619889322 · Cited by 36
Leung, C.-H., & Liu, C.-P. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.06.005 · Cited by 31
Shah, F. A., Mahmud, H., Gallego‐Martin, T., Jurczak, M. J., O'Donnell, C. P., & McVerry, B. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00296 · Cited by 32
Chen, X., Chen, Y., Wu, C., Wei, M., Xu, J., Chao, Y.-C., Song, J., Hou, D., Zhang, Y., Du, C., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001851 · Cited by 29
Glucose Management Technologies for the Critically Ill
Salinas, P. D., & Mendez, C. E. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822838 · Cited by 31
The alterations of innate immunity and enhanced severity of infections in diabetes mellitus
Zhou, Z. Q., Wang, H., Tan, S., Zhang, H., & Zhu, Y. (2023) · Immunology · doi:10.1111/imm.13706 · Cited by 35
Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia
Whitlock, A. E. G., Sostre‐Colón, J., Gavin, M. J., Martin, N. D., Baur, J. A., Sims, C. A., & Titchenell, P. M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101246 · Cited by 29
“com survival, especially in trauma, sepsis, and lung injury in which stressinduced hyperglycemia is associated with as high as a two-fold increase in mortality [7,12,15,16].”
BackgroundPrognostic indicators in cats with septic peritonitis (2002–2015): 83 cases
Scotti, K. M., Koenigshof, A. M., Sri-Jayantha, L. S. H., Kato, M., Bishop, M. A., Barr, J. W., & Pashmakova, M. B. (2019) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12896 · Cited by 26
Gruenbaum, S. E., Toscani, L., Fomberstein, K., Ruskin, K. J., Dai, F., Qeva, E., Rosa, G., Meng, L., & Bilotta, F. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001946 · Cited by 26
Pérez-Calatayud, Á. A., Guillén-Vidaña, A., Fraire-Félix, I. S., Malagón, E. D. A., Garduño, J. C. B., & Carrillo-Esper, R. (2016) · Cirugía y Cirujanos · doi:10.1016/j.circir.2016.10.026 · Cited by 25
High sugar diets can increase susceptibility to bacterial infection in Drosophila melanogaster
Darby, A. M., Okoro, D. O., Aredas, S., Frank, A. M., Pearson, W. H., Dionne, M., & Lazzaro, B. P. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012447 · Cited by 29
High prevalence of diabetes and anthropometric heterogeneity among tuberculosis patients in Pakistan
Aftab, H., Ambreen, A., Jamil, M., Garred, P., Petersen, J. H., Nielsen, S. D., Bygbjerg, I. C., & Christensen, D. L. (2017) · Tropical Medicine & International Health · doi:10.1111/tmi.12842 · Cited by 24
“) Several studies have shown that transient hyperglycaemia is associated with increased mortality(38, 39).”
BackgroundMoreira, J., Castro, R., Lamas, C. D. C., Ribeiro, S. R., Grinsztejn, B. G. J., & Veloso, V. G. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.12.014 · Cited by 24
“Hyperglycemia is a marker of illness severity and a wellrecognized predictor of mortality across a diverse spectrum of conditions, including pneumonia (McAlister et al., 2005), sepsis (van Vught et al., 2016), and critical illness (van den Berghe et al., 2001; Krinsley, 2003).”
BackgroundPuskarich, M. A., McHugh, C. E., Flott, T. L., Karnovsky, A., Jones, A. E., & Stringer, K. A. (2020) · Shock · doi:10.1097/shk.0000000000001687 · Cited by 22
“Clin Infect Dis 65(9):1565-1569, 2017.”
BackgroundCorrao, S., Nobili, A., Natoli, G., Mannucci, P. M., Perticone, F., Pietrangelo, A., Argano, C., on behalf of the REPOSI Investigators, Mannucci, P. M., Nobili, A., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01716-8 · Cited by 23
“Our findings are in agreement with previous studies that found a strong association between severe hyperglycemia (glucose >200 mg/dL) and 30-day risk of mortality in critical ill patients with sepsis [20].”
ResultWernly, B., Lichtenauer, M., Franz, M., Kabisch, B., Muessig, J. M., Masyuk, M., Kelm, M., Hoppe, U. C., & Jung, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091586 · Cited by 22
“In septic patients severe hyperglycemia (blood glucose >200 mg/dL) but not mild hyperglycemia (141–199 mg/dL) was recently reported to be associated with increased mortality [8].”
BackgroundOliveira, A. S., do Nascimento, J. R., Trovão, L. O., Alves, P. C. S., Maciel, M. C. G., Silva, L. D. M., Marques, A. A., Santos, A. P. S. A., Silva, L. A., do Nascimento, F. R. F., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.03.014 · Cited by 26
GC/MS-based metabonomics approach reveals effects of Xuebijing injection in CLP induced septic rats
Jiang, Y., Zou, L., Liu, S., Liu, X., Chen, F., Liu, X., & Zhu, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109163 · Cited by 21
Admission hyperglycemia and outcome in ICU patients with sepsis
Robba, C., & Bilotta, F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.06.09 · Cited by 20
“(11) explored the relationship between admission blood glucose concentration and outcome in septic patients admitted to ICU and addressed some important points regarding this topic.”
BackgroundWernly, B., Jirak, P., Lichtenauer, M., Franz, M., Kabisch, B., Schulze, P. C., Braun, K., Muessig, J. M., Masyuk, M., Paulweber, B., et al. (2018) · Medical Principles and Practice · doi:10.1159/000496205 · Cited by 20
Wentowski, C. C., Mewada, N., & Nielsen, N. D. (2018) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2018.11.009 · Cited by 21
Association between hyperglycemia and adverse clinical outcomes of sepsis patients with diabetes
Lin, S., Lai, D., & He, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1046736 · Cited by 18
Hsieh, M., Hu, S.-Y., How, C., Seak, C., Hsieh, V. C., Lin, J.-W., & Chen, P. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819875406 · Cited by 18
Xia, W., Li, C., Kuang, M., Wu, Y., Xu, L., & Hu, H. W. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03278-z · Cited by 17
The Bitter and the Sweet: Relationship of Lactate, Glucose, and Mortality After Severe Blunt Trauma
Richards, J. E., Mazzeffi, M. A., Massey, M. S., Rock, P., Galvagno, S. M., & Scalea, T. M. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005335 · Cited by 17
Lin, S., Ge, S., He, W., & Zeng, M. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4360 · Cited by 16
“although that study had a small sample size and involved only 218 sepsis patients with comorbid DM (18).”
BackgroundKant, R., Naithani, M., Jain, G., Kumar, A., & Sama, S. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24043 · Cited by 16
Machine learning approaches to the human metabolome in sepsis identify metabolic links with survival
Kosyakovsky, L. B., Somerset, E., Rogers, A. J., Sklar, M. C., Mayers, J. R., Toma, A., Szekely, Y., Soussi, S., Wang, B., Fan, C. S., et al. (2022) · Intensive Care Medicine Experimental · doi:10.1186/s40635-022-00445-8 · Cited by 16
“Stress hyperglycemia and glycemic variability are associated with sepsis mortality, and accordingly this link may provide further corroboration and insight into this interaction [37, 38].”
BackgroundLin, S., He, W., & Zeng, M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s287510 · Cited by 15
He, J., Zheng, G., Qian, X., Sheng, H., Chen, B., Zhao, B., Chen, E., Mao, E., & Bian, X. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1887832 · Cited by 15
Issarawattana, T., & Bhurayanontachai, R. (2020) · Critical Care Research and Practice · doi:10.1155/2020/5071509 · Cited by 15
Inter-relationships between gastric emptying and glycaemia: Implications for clinical practice
Murthy, T. A., Chapman, M. J., Jones, K. L., Horowitz, M., & Marathe, C. S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.447 · Cited by 17
Feng, M., & Zhou, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-55504-9 · Cited by 14
Wayland, J., Teixeira, J. P., & Nielsen, N. D. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.06.010 · Cited by 16
Pulse contour cardiac output monitoring in acute heart failure patients
Wernly, B., Lichtenauer, M., Franz, M., Fritzenwanger, M., Kabisch, B., Figulla, H., & Jung, C. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-1048-z · Cited by 14
Incidence and Impact of Dysglycemia in Patients with Sepsis Under Moderate Glycemic Control
Fujishima, S., Gando, S., Saitoh, D., Kushimoto, S., Ogura, H., Abe, T., Shiraishi, A., Mayumi, T., Sasaki, J., Kotani, J., et al. (2021) · Shock · doi:10.1097/shk.0000000000001794 · Cited by 14
“With regard to sepsis, an admission blood glucose level of 200 mg/dL was found to be a risk factor for poor prognosis (15, 23).”
BackgroundResultPrecision Glycemic Control in the ICU*
Marik, P. E. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001683 · Cited by 16
Hyperglycemia and outcomes in patients with sepsis
NUGENT, K. M., Edriss, H., & Selvan, K. C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.63 · Cited by 13
“All studies investigating the relationship between hyperglycemia and outcomes in patients with sepsis need to consider patient characteristics and co-morbidity at presentation, adverse events during the hospitalization, and, in particular, the presence or absence of diabetes prior to hospitalization (1).”
BackgroundMethodInfluentialGe, Y., Wang, Z., Ma, Y., & Zhang, C. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112217 · Cited by 11
Zhou, J. H., Chen, Z., Huang, H., Ou, C., & Li, X. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01580-4 · Cited by 11
Pérez-Calatayud, Á. A., Guillén-Vidaña, A., Fraire-Félix, I. S., Malagón, E. D. A., Garduño, J. C. B., & Carrillo-Esper, R. (2017) · Cirugía y Cirujanos (English Edition) · doi:10.1016/j.circen.2016.10.005 · Cited by 11
McGrade, P., Yang, S., & NUGENT, K. M. (2019) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2019.1611318 · Cited by 11
Glucose and Lactate Levels at Admission as Predictors of In-hospital Mortality
Sotello, D., Yang, S., & NUGENT, K. M. (2019) · Cureus · doi:10.7759/cureus.6027 · Cited by 11
Farooq, N., Chuan, B. W., Mahmud, H., Khoudary, S. R. E., Nouraie, M. S., Evankovich, J. W., Yang, L., Dunlap, D. G., Bain, W., Kitsios, G. D., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248853 · Cited by 11
“Clinical studies of the relationship between the host immune response and the occurrence of hyperglycemia in septic patients are limited and have yielded conflicting results [7, 20, 21].”
BackgroundResultFeng, S., Zou, R., Wang, Y., Huang, Y., Zhou, Q., Huang, Q., & Xu, H. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11151-7 · Cited by 10
Wei, X., Min, Y., Yu, J.-C., Wang, Q., Wang, H., Li, S., & Su, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.757061 · Cited by 10
Hung, K.-Y., Tsai, Y., Lin, C.-Y., Chang, Y.-C., Wang, Y.-H., Lin, M., & Fang, W. (2021) · Diagnostics · doi:10.3390/diagnostics11101798 · Cited by 10
“Although admission for severe hyperglycemia was associated with increased mortality in both DM and non-DM patients in a previous report [23], we found that the phenomenon was more obvious when using the peak glucose level instead of the admission glucose level.”
BackgroundShah, F. A., Singamsetty, S., Guo, L., Chuan, B. W., McDonald, S., Cooper, B. A., O’Donnell, B. J., Stefanovski, D., Wice, B. M., Zhang, Y., et al. (2017) · Translational research · doi:10.1016/j.trsl.2017.11.001 · Cited by 10
“increased short- and long-term mortality.(29-31) Maintaining euglycemia in septic patients remains challenging because of the complex balance between the effects of acute illness and inflammation, the disruption of endocrine pathways responsible for glucose disposal, and the intentional and unintentional effects of th…”
Luethi, N., Cioccari, L., Eastwood, G. M., Biesenbach, P., Morgan, R., Sprogis, S. K., Young, H., Peck, L., Chong, C. K., Moore, S., et al. (2019) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13354 · Cited by 10
Li, Y., Li, W., & Xu, B. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14182 · Cited by 9
“In addition, individuals without diabetes with increased glucose concentrations showed a decreased responsiveness of whole blood leukocytes after ex vivo stimulation with endotoxin, and hyperglycemia inhibited innate immune response in various conditions 30 .”
BackgroundWentowski, C. C., Inglés, D. P., & Nielsen, N. D. (2021) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2021.10.001 · Cited by 11
Stress-induced hyperglycemia and mortality of non-diabetic patients with sepsis: a meta-analysis
Huang, J., Li, J., Chen, X., & Gu, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1688494 · Cited by 8
Rao, S., Ali, K., Dennis, J. A., Berdine, G. G., Test, V. J., & NUGENT, K. M. (2020) · Journal of Primary Care & Community Health · doi:10.1177/2150132720958533 · Cited by 8
Parlițeanu, O.-A., Bălteanu, M. A., Zaharia, D. C., Constantinescu, T., Cristea, A. M., Dumitrache‐Rujinski, S., Nica, A. E., Voineag, C., Alexe, O., Tabacu, E., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15050554 · Cited by 7
Beyond diabetes: harnessing the power of metformin in burn care
Khalaf, F., Touma, D., Saldanha, S., Khalaf, G., Barayan, D., & Jeschke, M. G. (2025) · Critical Care · doi:10.1186/s13054-025-05662-7 · Cited by 9
“In critically ill septic patients, only severe hyperglycemia (> 200 mg/dL) on admission was associated with increased 30-day mortality, whereas mild hyperglycemia (141–199 mg/dL) did not show the same detrimental impact [20].”
Olander, A., Magnusson, C. G. M., Sundler, A. J., Bremer, A., Andersson, H., Herlitz, J. D., Axelsson, C., & Hagiwara, M. A. (2023) · Prehospital and Disaster Medicine · doi:10.1017/s1049023x23000110 · Cited by 7
Mehta, P. B., Kohn, M. A., Rov-Ikpah, E., San Luis, C., Johnson, C., Lee, G., Koliwad, S., & Rushakoff, R. J. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241232673 · Cited by 7
Machine learning glucose forecasting models for septic patients
Cao, X. G., Wang, D., He, J.-X., Hou, J., Li, J., Jiang, H., & Wang, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-23057-0 · Cited by 6
Rodríguez-Calero, M. Á., Llodrá, E. B., Cuberos, M. C., Blanco‐Mavillard, I., & Axartell, M. A. P. (2019) · Enfermería Intensiva (English ed ) · doi:10.1016/j.enfie.2018.01.004 · Cited by 6
Jin, X., Deng, W., Weng, Q., Liu, F., & Jia, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-18349-4 · Cited by 5
“Consistently, Vught et al. 28 demonstrated that sepsis patients with hyperglycemia at admission were significantly correlated with poor prognostic outcomes, irrespective of the presence of diabetes.”
Rodríguez-Calero, M. Á., Llodrá, E. B., Cuberos, M. C., Blanco‐Mavillard, I., & Axartell, M. A. P. (2018) · Enfermería Intensiva · doi:10.1016/j.enfi.2018.01.004 · Cited by 5
Shao, Y., Shao, F., Zhou, J., Fang, S., Zhu, J., & Li, F. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/166656 · Cited by 7
Rosenthal, J., Lord, A. S., Ishida, K., Torres, J., Czeisler, B. M., & Lewis, A. K. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.05.030 · Cited by 5
Ning, D., Garg, K., Mayer, B., Schick, B., Bracht, H., Barth, E., Weiss, M., Li, C., Schneider, J., & Schneider, E. M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1026298 · Cited by 5
Bellaver, P., Schneider, L., Schaeffer, A. F., Henrique, L. R., Camargo, J. L., Gerchman, F., Leitão, C. B., & Rech, T. H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18554 · Cited by 5
Ren, J., Zhang, C., Liu, Y.-H., Han, H., Liang, Y., Zhang, Q., Li, S., Benn, B. S., NUGENT, K. M., Qu, H., et al. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-854 · Cited by 4
Admission hyperglycemia in sepsis is associated with poor outcomes: where do we go from here?
Szumita, P. M., & Gilmore, J. F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.17 · Cited by 4
“Findings from van Vught and colleagues evaluating the relationship between initial blood glucose (BG) value and mortality, as well as changes in the host response, add to the evidence suggesting hyperglycemia is associated with poor outcomes in the subset of critically ill patients with sepsis (3).”
BackgroundInfluentialTargeted Glycemic Control for Adult Patients With Type 2 Diabetes Mellitus in the Acute Care Setting
Pourmand, A., Mazer-Amirshahi, M. E., Caggiula, A., Nawab, A., Payette, C., & Johnson, S. G. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.01.015 · Cited by 4
Procalcitonin and qSOFA as a Marker of Mortality in Sepsis.
Parrey, A. H., Koka, M., Kassana, B. A., & Ismail, M. (2024) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871288534240322083746 · Cited by 4
Mahmoudi, P. S., Sadeghi, F., Saberian, M., Khalili, H., & Shafaati, M. (2026) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00335-x · Cited by 3
“Severe admission hyperglycemia ( ≥ 200 mg/dL) is independently associated with increased 30-day mortality in patients without a history of diabetes, with an adjusted hazard ratio of 1.65 (95% CI 1.12–2.42) [65].”
InfluentialAl‐Taie, A., Arueyingho, O., Khoshnaw, J., & Hafeez, A. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2086265 · Cited by 3
“It is common among acute hospital admissions and critically ill patients and is associated with an increase of poor outcomes and mortality in hospitalised patients (van Vught et al. 2016, Khateeb et al .”
BackgroundCorticosteroids in Lung and Pleural Infections
Badiei, A., Chan, K. P., Lee, G., & WATERER, G. W. (2018) · Current Pulmonology Reports · doi:10.1007/s13665-018-0197-0 · Cited by 3
Mohamed, A. O., Megied, M. A. A. E., & Hosni, Y. A. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24546 · Cited by 2
Meška, D., Schroer, S., Odensass, S., Gümüs, M., Rieß, C., Dinger, T. F., Rauschenbach, L., Engel, A., Oppong, M. D., Ahmadipour, Y., et al. (2024) · Medicina · doi:10.3390/medicina60111862 · Cited by 2
“…observational cohort study including 987 sepsis patients, reported on an association between hyperglycemia at admission with an adverse outcome of sepsis irrespective of the presence or absence of preexisting diabetes, by a mechanism unrelated to exaggerated inflammation or coagulation [36].”
Huang, M. L., Li, D., Chuanlai, Z., Yang, R., Bai, X., & Gan, X. (2025) · Nursing in Critical Care · doi:10.1111/nicc.70080 · Cited by 2
“…studies further validated that the use of IIPs with a more liberal range is becoming more common in the prevention of hypoglycaemia [10], with common target glycaemic control ranges of 7.9–10 mmol/L (140–180 mg/dL) [6], 6.1–11.1 mmol/L (110–200 mg/dL) [11] and 10–11.1 mmol/L (180–200 mg/dL) [12].”
InfluentialHigh sugar diets can increase susceptibility to bacterial infection in Drosophila melanogasterPreprint
Darby, A. M., Okoro, D. O., Aredas, S., Frank, A. M., Pearson, W. H., Dionne, M., & Lazzaro, B. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.07.570705 · Cited by 2
Guideline-Concordant Insulin Infusion Initiation Among Critically Ill Patients With Sepsis
Bosch, N. A., Fantasia, K. L., Modzelewski, K. L., Alexanian, S. M., & Walkey, A. J. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.018 · Cited by 1
Song, Y., Wang, X., Chen, C., Wei, T., Lang, K., Yang, D., & Song, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.755536 · Cited by 1
Muhetaer, G., Sun, C., Ma, Q., Zhang, Y., Zhang, J., & Ning, Y. (2025) · Nursing in Critical Care · doi:10.1111/nicc.13304 · Cited by 1
Impact of streptozotocin-induced hyperglycemia on the host response to sepsis
Carlin, S., Dwivedi, D. J., Cani, E., Sharma, N., Venegas-Pino, D. E., Lalu, M. M., Mendelson, A. A., McDonald, B., Werstuck, G. H., & Liaw, P. C. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.07.004 · Cited by 1
Azab, A. E., Alawaini, K. A., Albakoush, A. M., Kushlaf, N. A., Abdalla, S., & Mohamed, S. (2021) · Biotechnology and Bioprocessing · doi:10.31579/2766-2314/043 · Cited by 1
“Hyperglycemia can occur in diabetic and non-diabetic patients hospitalized for COVID-19 and is common among acute hospital admissions and critically ill patients, encompassing those with no previous history of hyperglycemia [9-11].”
BackgroundShah, F. A., Kitsios, G. D., Yende, S. P., Dunlap, D. G., Scholl, D., Chuan, B. W., Al‐Yousif, N., Zhang, Y., Nouraie, M. S., Morris, A., et al. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000550 · Cited by 3
Development and Validation of an Ensemble Learning Risk Model for Sepsis After Abdominal Surgery
Shu, X., Li, Y., Zhu, Y., Yang, Z., Liu, X., Hu, X., Yang, C., Жао, Л., Zhu, T., Chen, Y., et al. (2024) · Archives of Medical Science · doi:10.5114/aoms/189505 · Cited by 1
“High glucose levels at sepsis onset have been proved to be independently associated with a worse prognosis, irrespective of the presence or absence of preexisting diabetes [37, 38].”
Metadata
- Authors
- van Vught, L. A., Wiewel, M. A., Klein Klouwenberg, P. M. C., Hoogendijk, A. J., Scicluna, B. P., Ong, D. S. Y., Cremer, O. L., Horn, J., Bonten, M. M. J., Schultz, M. J., & van der Poll, T.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- University Medical Center Utrecht (NL)
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
- ORCID
- Venue
- Critical Care Medicine
- Published
- 2016-07
- Volume
- 44
- Issue
- 7
- Pages
- 1338-1346
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2295634666
- Cited by
- 130
- References
- 49
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 10 · 2023: 16 · 2022: 8 · 2021: 16 · 2020: 14 · 2019: 17 · 2018: 9 · 2017: 7 · 2016: 9
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- Center for Translational Molecular Medicine (04I-201)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- sepsis, admission hyperglycemia, critically ill patients, host response biomarkers, diabetes mellitus, 30-day mortality, cytokine network, vascular endothelium, coagulation, plasma biomarkers, intensive care
- MeSH terms
- Aged, Female, Hospitalization, Hospitals, Teaching, Humans, Hyperglycemia, Intensive Care Units, Male, Middle Aged, Prospective Studies, Critical Illness, Sepsis, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review